PACAP stimulates the release of interleukin-6 in cultured rat Müller cells

Area of Science:

• Neuroscience
• Ophthalmology
• Cell Biology

Background:

• Müller cells are the primary glial cells in the retina, playing crucial roles in retinal structure and function.
• Pituitary adenylate cyclase-activating polypeptide (PACAP) is known to have neuroprotective effects in various tissues, including the nervous system.
• The specific mechanisms by which PACAP exerts neuroprotection within the retina, particularly its interaction with Müller cells, require further elucidation.

Purpose of the Study:

• To investigate the in vivo effects of PACAP on rat Müller cells.
• To determine if PACAP influences Müller cell proliferation and the production of interleukin-6 (IL-6).
• To identify the expression of PACAP receptors (PAC1-R) on Müller cells.

Main Methods:

• Rat Müller cells were treated with PACAP38, alone or with the antagonist PACAP6-38.
• Cellular proliferation was assessed using bromodeoxyuridine incorporation.
• Interleukin-6 (IL-6) levels were measured via a B9 cell bioassay.
• PACAP receptor (PAC1-R) expression was evaluated using immunohistochemistry.

Main Results:

• PACAP stimulated IL-6 production in Müller cells at very low concentrations (10(-12) M).
• PACAP did not induce significant Müller cell proliferation at the tested concentrations.
• The PACAP-induced IL-6 release was significantly inhibited by the PACAP-selective antagonist PACAP6-38.
• PACAP receptor (PAC1-R) expression was confirmed on cultured rat Müller cells.

Conclusions:

• Müller cells are identified as target cells for PACAP in the retina.
• PACAP stimulates IL-6 release from Müller cells, suggesting a key mechanism for its neuroprotective actions.
• These findings provide a molecular basis for PACAP's significant neuroprotective effects in retinal injury or disease.